They paid about 2x BLUE book value which for EPNY would be around $6, plus as bad as EPNY is BLUE was in more dire straits, EPNY actually looks good compared to BLUE, after all EPNY had at least had 1 profitable qtr(LOL).
Blue paid 17.1 for 28.3 in rev after you back out cash on hand of 32.9. Which means they paid .604% times sales.
So applying that to revenues of 79.3 for EPNY gives 47.9 (say 48) Add to cash on hand of 251 and divide by 77 mil shares gives 3.88.
So even though the return wouldnt be great it seems like a no brainer to buy at 3.4 or lower.
My thinking is they can squeeze a lot more fat out of 79 million in sales. And we can debate if EPNY has more brand then BLUE. I think they do. The point we are making is this is cheap and may yet get cheaper. We have already had a preview of next quarter and know it doesnt look pretty.
The bottomline is the clock is ticking for shareholders. Karen needs to step up and make a decision. Sell before we have nothing or demonstrate a plan to maximize value and profitability quickly before equity erodes to nothing. This, in my opinion, is not the time to be a stand alone entity. Combine or sell to an equity firm. Its to costly and to competitive to be this size player.
Karen, do what is right for shareholders and what is in the best interest of your employees. Watching the business erode just means a spiral of lost and laid off employees. Find a situation that works for them as well.
Its simple EPNY managment. Its time to do the right thing.